L-glutamine, also known as glutamine, is an amino acid. Amino acids are organic compounds often referred to as the building blocks of proteins. They play critical roles in health, such as building ...

Is IBD an autoimmune disease? While it has similarities with autoimmune diseases, IBD is a little different. IBD falls under the umbrella of immune-mediated inflammatory diseases (IMIDs).

Adjunct therapies like the Mediterranean diet, exercise, and CBT can improve quality of life for IBS and IBD patients by reducing persistent digestive symptoms. Despite standard drug treatments ...

Makhana, or fox nuts, comes from the Euryale ferox plant and is widely grown in Asia. Known for its rich nutrients and ...

Inflammatory bowel disease (IBD) is a group of intestinal disorders that cause prolonged inflammation of the digestive tract. It can include ulcerative colitis (UC) or Crohn’s disease.

L-glutamine, a non-essential amino acid, is vital for muscle recovery and enhancing the immune system. It is the most prevalent amino acid in the human body and frequently found in food sources ...

IBD is an overarching term for two conditions: Crohn's disease and ulcerative colitis. Inflammatory bowel disease is a term that encompasses two conditions: Crohn’s disease and ulcerative ...

It is hoping that a phase 2 trial in ulcerative colitis called IM011-127, which is using a higher dose of the drug and is due to generate results next year, will set the programme back on track.

CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS. The FDA has approved Omvoh for the treatment of moderately to ...

Previously approved for ulcerative colitis in October 2023, Omvoh (mirikizumab-mrkz) enters an increasingly crowded IBD drug market following the approval of rival IL-23p19 inhibitor Skyrizi ...

“The prevalence of IBD continues to increase, and many people living with ulcerative colitis and Crohn’s disease do not respond to current therapies,” said Jonathon Sedgwick, AbbVie’s ...